Kyverna Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
KYTX
CUSIP
501976104
Type
Equity
Class
COM
Num filings
83
Total reported value, excl. options
$71.4 M
Manager Report Date Value ($000) Shares Option Type